Expansion at Montreal Heart
Institute’s Research Centre
MONTREAL - The Montreal Heart
Institute has been given the authorization to expand its Research Centre
at a cost of $33,915,000. In addition to $21,828,200 from the Government
of Quebec, this project is financed by the MHI Foundation ($10,021,900)
and the Agence de la santé et des services sociaux de Montréal
($1,833,300). The MHI, for its part, is contributing the sum of
“This announcement shows that the Montreal Heart Institute enjoys the
confidence of the Government of Quebec, specifically in regards to its
leadership role in cardiovascular research. This tangible support from
the Government of Quebec and the MHI Foundation will help create optimal
conditions for developing new knowledge and achieving important
breakthroughs,” said Mr. Jean Royer, Chair of the Montreal Heart
Institute’s Board of Directors.
The MHI Research Centre expansion project stands as a cornerstone in the
development of leading-edge research activities at the MHI and as a
progressive step forward in terms of its international influence and
stature. This construction project, slated for completion in the fall of
• expanding the South block (Pavillon Jean-Louis Lévesque) by 6,599
square metres, distributed over three floors;
• adding three new fundamental research laboratories;
• partially reorganizing the existing first three floors of the Research
Centre’s South block;
• constructing a space that in future will be laid out and used for
catheterization activities for research purposes.
“The Research Centre expansion will have several significant effects on
the MHI, and these will translate into benefits for patients at the MHI,
as well as patients in Quebec and Canada,” said Dr. Jean-Claude Tardif,
Director of the MHI Research Centre.
It will make for:
• the recruitment of many researchers of international stature and
further progress for the excellent researchers already present at the
• the addition of new research laboratories in genetics, arrhythmias,
vascular electrophysiology, regenerative medicine, mathematical
modelling and metabolomics;
• the expansion of many fundamental research laboratories in vascular
pharmacology, endothelial function, proteomics, cardiac biochemistry,
cardiovascular imaging, atherosclerosis, coronary procedures, molecular
electrophysiology and cardiovascular rheology;
• the expansion and reorganization of the animal housing facility
(particularly for transgenic mice);
• the reorganization and expansion of clinical research infrastructures
now partly located in temporary structures.
“The Research Centre expansion will have major benefits in terms of the
MHI’s capacity to achieve significant breakthroughs in the prevention
and treatment of cardiovascular diseases, while generating intellectual
property as well as profitable economic spinoffs for Quebec,” added Mr.
Robert Busilacchi, Executive Director of the MHI.
Research at the Heart of a Resounding Success
On June 18, 2009, the Montreal Heart Institute and its partners received
$53 million for projects from the Canada Foundation for Innovation and
the Government of Quebec. With these major investments in sophisticated
medical imaging, genomics, metabolics and high-throughput biology, the
Montreal Heart Institute will be thrust into the world’s top ranks of
cutting-edge fundamental and clinical research leading to important
breakthroughs in the early and more refined diagnosis, prevention and
treatment of cardiovascular diseases. Together with its other
infrastructures, such as the Beaulieu-Saucier Pharmacogenomics Centre,
the Centre for Excellence in Personalized Medicine, and the MHI Research
Centre, the MHI will continue its transformative research leading to a
more preventive, predictive and personalized approach to healthcare.
About the Montreal Heart Institute:
About the Université de Montréal:
Posted July 16/09.